Cooper Companies
COO
Market cap $13.9B

69.70 USD

-1.18

1.66%

At close Jun 13, 4:00 PM EDT

After hours

68.72

-0.98

1.41%

1 day

-1.66%

5 days

-4.22%

1 month

-14.75%

3 months

-10.33%

6 months

-26.52%

Year to date

-23.12%

1 year

-26.01%

5 years

-3.98%

10 years

58.16%

About: CooperCompanies is one of the largest eyecare companies in the US. It operates in two segments: CooperVision and CooperSurgical. CooperVision is a pure-play contact lens business with a suite of spherical, multifocal, and toric contact lenses. The company also has one of the most comprehensive specialty lens portfolios in the world. With brands including Proclear, Biofinity, MyDay, and Clariti, Cooper controls roughly one fourth of the US contact lens market. CooperSurgical, founded in 1990, is made up of equipment related to reproductive care, fertility, and women's care. Cooper has the broadest medical device coverage of the entire IVF cycle. It also has Paragard, the only hormone-free IUD in the US, and controls 17% of the US IUD market.

Employees: 16,000

Healthcare Medical Instruments & Supplies

0

Funds holding %

of 7,296 funds

0

Analysts bullish %

of 4 analysts

Fund manager confidence

Based on 2025 Q1 regulatory disclosures by fund managers ($100M+ AUM)

25% more funds holding in top 10

Funds holding in top 10: 4 [Q4 2024] → 5 (+1) [Q1 2025]

0.51% less ownership

Funds ownership: 98.02% [Q4 2024] → 97.51% (-0.51%) [Q1 2025]

7% less funds holding

Funds holding: 670 [Q4 2024] → 626 (-44) [Q1 2025]

9% less capital invested

Capital invested by funds: $18B [Q4 2024] → $16.4B (-$1.54B) [Q1 2025]

10% less repeat investments, than reductions

Existing positions increased: 223 | Existing positions reduced: 249

34% less first-time investments, than exits

New positions opened: 66 | Existing positions closed: 100

36% less call options, than puts

Call options by funds: $29.1M | Put options by funds: $45.3M

See Fund Rankings

Research analyst outlook

4 Wall Street Analysts provided 1 year price targets over the past 3 months

Low target

$76

9%

upside

Avg. target

$93

33%

upside

High target

$105

51%

upside

4 analyst ratings

3 positive

75%

1 neutral

25%

0 negative

0%

Baird Jeff Johnson	39%upside $97	Outperform Maintained	30 May 2025
Piper Sandler Jason Bednar	51%upside $105	Overweight Reiterated	30 May 2025
Wells Fargo Larry Biegelsen	33%upside $93	Overweight Maintained	30 May 2025
JP Morgan Robbie Marcus	9%upside $76	Neutral Downgraded	30 May 2025

See Analyst Rankings

Financial journalist opinion

Based on 16 articles about COO published over the past 30 days

3 Oversold Stocks Flashing Bullish Reversal Signals

When it comes to short-term trading signals, few indicators are as closely tracked as the Relative Strength Index (RSI). A stock's RSI measures the speed and magnitude of its recent price movements.

3 Oversold Stocks Flashing Bullish Reversal Signals

Zacks Investment Research

Why The Cooper Companies (COO) is a Top Growth Stock for the Long-Term

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

Why The Cooper Companies (COO) is a Top Growth Stock for the Long-Term

Zacks Investment Research

Understanding The Cooper Companies (COO) Reliance on International Revenue

Explore The Cooper Companies' (COO) international revenue trends and how these numbers impact Wall Street's forecasts and what's ahead for the stock.

Understanding The Cooper Companies (COO) Reliance on International Revenue

Zacks Investment Research

COO Q2 Earnings Signal Growth and Caution: How to Play the Stock?

Cooper Companies COO delivered a solid fiscal second quarter performance in 2025, surpassing analyst expectations with $1 billion in revenue (up 6.3% YoY) and adjusted earnings per share (EPS) of 96 cents (up 14% YoY). Despite persistent macroeconomic headwinds and a slightly softened outlook for industry growth, management reaffirmed confidence in its core product momentum and operational leverage.

COO Q2 Earnings Signal Growth and Caution: How to Play the Stock?

Zacks Investment Research

XRAY vs. COO: Which Stock Should Value Investors Buy Now?

Investors looking for stocks in the Medical - Dental Supplies sector might want to consider either Dentsply International (XRAY) or The Cooper Companies (COO). But which of these two stocks offers value investors a better bang for their buck right now?

XRAY vs. COO: Which Stock Should Value Investors Buy Now?

Top Stock Movers Now: Regeneron, Ulta Beauty, Cooper, and More

U.S. equities were lower at midday as the market focused on the future of U.S.-China trade. The Dow Jones Industrial Average, S&P 500, and Nasdaq all lost ground.

Top Stock Movers Now: Regeneron, Ulta Beauty, Cooper, and More

Zacks Investment Research

COO Q2 Earnings Beat, 2025 Sales Outlook Tightened, Stock Down

COO's fiscal Q2 earnings and sales beat market expectations on the back of strong growth. Improvement in operating margin bodes well.

COO Q2 Earnings Beat, 2025 Sales Outlook Tightened, Stock Down

The Cooper Companies, Inc. (COO) Q2 2025 Earnings Call Transcript

The Cooper Companies, Inc. (NASDAQ:COO ) Q2 2025 Results Conference Call May 29, 2025 5:00 PM ET Company Participants Kim Duncan - Vice President, Investor Relations & Risk Management Al White - President & Chief Executive Officer Brian Andrews - Chief Financial Officer & Treasurer Conference Call Participants Jeff Johnson - Baird Issie Kirby - Redburn Atlantic Larry Biegelsen - Wells Fargo Jon Block - Stifel Robbie Marcus - JPMorgan Craig Bijou - Bank of America Joanne Wuensch - Citi Young Li - Jefferies Chris Pasquale - Nephron Research Jason Badner - Piper Sandler Brett Fishbin - KeyBanc Steve Lichtman - Oppenheimer David Saxon - Needham & Company Navann Ty - BNP Paribas Operator Thank you for standing by. At this time, we would like to welcome you to the Q2 2025 Cooper Companies Earnings Conference Call.

The Cooper Companies, Inc. (COO) Q2 2025 Earnings Call Transcript

Cooper Companies raises 2025 profit forecast on contact lens demand

Cooper Companies raised its annual profit forecast on Thursday, after beating quarterly results estimates, banking on strong demand for its contact lenses.

Cooper Companies raises 2025 profit forecast on contact lens demand

Zacks Investment Research

The Cooper Companies (COO) Reports Q2 Earnings: What Key Metrics Have to Say

Although the revenue and EPS for The Cooper Companies (COO) give a sense of how its business performed in the quarter ended April 2025, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.

The Cooper Companies (COO) Reports Q2 Earnings: What Key Metrics Have to Say

See News Rankings

Charts implemented using Lightweight Charts™